Institutional Ownership Prime Medicine, Inc. (PRME)
This table provides information about the institutional ownership of Prime Medicine, Inc. (PRME). We have compiled data on the 130 institutions that hold shares in the stock, with a total of 57.6 Million shares, which have been reported (via 13F filing form) to have a value of $93.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Alphabet Inc.
Mountain View, CA |
May 01, 2025 Q1 2025 |
15,062,498
shares
|
$24.4 Million
2.67% of portfolio
|
Q1 2024
Added 26.98%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,110,418
shares
|
$8.28 Million
0.0% of portfolio
|
Q2 2024
Added 36.05%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 14, 2025 Q1 2025 |
4,143,096
shares
|
$6.71 Million
0.01% of portfolio
|
Q1 2025
Added 4.15%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,641,348
shares
|
$5.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.38%
|
|
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
May 07, 2025 Q1 2025 |
3,095,172
shares
|
$5.01 Million
0.07% of portfolio
|
Q1 2025
Reduced 39.9%
|
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Apr 25, 2025 Q1 2025 |
2,926,023
shares
|
$4.74 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.31%
|
|
|
Nikko Asset Management Americas, Inc.
|
May 07, 2025 Q1 2025 |
2,926,023
shares
|
$4.74 Million
0.08% of portfolio
|
Q1 2025
Reduced 5.31%
|
|
|
Redmile Group, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
2,074,350
shares
|
$3.36 Million
0.43% of portfolio
|
Q1 2024
Added 56.63%
|
|
|
Mwg Management Ltd.
Washington, DC |
May 13, 2025 Q1 2025 |
1,792,210
shares
|
$2.9 Million
6.07% of portfolio
|
Q2 2023
Reduced 2.38%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
1,779,945
shares
|
$2.88 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.05%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,567,192
shares
|
$2.54 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.09%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,526,530
shares
|
$2.47 Million
0.0% of portfolio
|
Q1 2025
Added 4.01%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
1,145,305
shares
|
$1.86 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.77%
|
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
1,028,466
shares
|
$1.67 Million
0.02% of portfolio
|
Q4 2022
New holding
|
|
|
Greenwich Wealth Management LLC
Greenwich, CT |
May 12, 2025 Q1 2025 |
819,001
shares
|
$1.33 Million
0.12% of portfolio
|
Q1 2025
Added 5.81%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
750,000
shares
|
$1.22 Million
0.01% of portfolio
|
Q1 2024
New holding
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
700,000
shares
|
$1.13 Million
0.11% of portfolio
|
Q1 2024
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
527,309
shares
|
$854,240
0.0% of portfolio
|
Q1 2025
Reduced 3.23%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
503,697
shares
|
$815,989
0.0% of portfolio
|
Q1 2025
Added 3.94%
|
|
|
Moore Capital Management, LP
New York, NY |
May 15, 2025 Q1 2025 |
500,000
shares
|
$810,000
0.02% of portfolio
|
Q1 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
447,600
shares
|
$725,112
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
May 15, 2025 Q1 2025 |
405,228
shares
|
$656,469
0.37% of portfolio
|
Q4 2024
Reduced 25.0%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
392,443
shares
|
$635,757
0.0% of portfolio
|
Q2 2024
Added 160.98%
|
|
|
Casdin Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
367,175
shares
|
$594,823
0.09% of portfolio
|
Q2 2023
Reduced 50.0%
|
|
|
Bollard Group LLC
Boston, MA |
May 15, 2025 Q1 2025 |
361,136
shares
|
$585,040
0.02% of portfolio
|
Q4 2023
New holding
|